论文信息 - Safety, Efficacy, and Biomarkers of Response to Azacitidine (AZA) with Nivolumab (Nivo) and AZA with Nivo and Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Phase 2 Study - 字舞流文

Safety, Efficacy, and Biomarkers of Response to Azacitidine (AZA) with Nivolumab (Nivo) and AZA with Nivo and Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Phase 2 Study

P. Sharma | M. Konopleva | Z. Estrov | J. Blando | J. Allison | H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | Koichi Takahashi | E. Jabbour | N. Daver | C. Dinardo | S. Pierce | S. Kornblau | J. Ning | R. Assi | N. Pemmaraju | S. Basu | J. Matthews | Y. Alvarado | M. Alfayez | W. Flores | G. Gonzalez